4//SEC Filing
REPLIGEN CORP 4
Accession 0001140361-16-055730
$RGENCIK 0000730272operating
Filed
Feb 29, 7:00 PM ET
Accepted
Mar 1, 2:40 PM ET
Size
9.0 KB
Accession
0001140361-16-055730
Insider Transaction Report
Form 4
REPLIGEN CORPRGEN
RUSCHE JAMES R
Senior Vice President
Transactions
- Award
Stock Option (Right to Buy)
2016-02-26+9,895→ 9,895 totalExercise: $26.05Exp: 2026-02-26→ Common Stock (9,895 underlying) - Tax Payment
Common Stock
2016-02-29$26.05/sh−1,419$36,965→ 100,516 total - Award
Common Stock
2016-02-26+5,086→ 101,935 total
Footnotes (3)
- [F1]Mr. Rusche was awarded 5,086 Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The Restricted Stock Units vest in equal annual installments over a three-year period beginning on the first anniversary of the grant date. The Restricted Stock Units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
- [F2]Payment of tax liability made via forfeiture of 1,419 shares of Common Stock valued at $26.05 per share on February 29, 2016.
- [F3]The shares vest in equal annual installments over a three-year period beginning on the first anniversary of the grant date.
Documents
Issuer
REPLIGEN CORP
CIK 0000730272
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000730272
Filing Metadata
- Form type
- 4
- Filed
- Feb 29, 7:00 PM ET
- Accepted
- Mar 1, 2:40 PM ET
- Size
- 9.0 KB